TuisNVZMF • OTCMKTS
add
Novozymes A/S
Vorige sluiting
$56,54
Jaarwisseling
$50,11 - $71,52
Markkapitalisasie
169,71 mjd DKK
Gemiddelde volume
760,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
CPH
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (EUR) | Jun. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 915,85 m | 61,70% |
Bedryfskoste | 271,75 m | 52,62% |
Netto inkomste | 31,95 m | -60,72% |
Netto winsgrens | 3,49 | -75,70% |
Wins per aandeel | — | — |
EBITDA | 150,94 m | -16,50% |
Effektiewe belastingkoers | 29,00% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (EUR) | Jun. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 260,80 m | 85,35% |
Totale bates | 15,25 mjd | 302,43% |
Totale aanspreeklikheid | 4,25 mjd | 119,23% |
Totale ekwiteit | 11,00 mjd | — |
Uitstaande aandele | 277,90 m | — |
Prys om te bespreek | 1,43 | — |
Opbrengs op bates | 1,83% | — |
Opbrengs op kapitaal | 2,15% | — |
Kontantvloei
Netto kontantverandering
| (EUR) | Jun. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 31,95 m | -60,72% |
Kontant van bedrywe | 264,05 m | 74,01% |
Kontant van beleggings | -27,45 m | 70,98% |
Kontant van finansiering | -186,70 m | -205,10% |
Netto kontantverandering | 55,55 m | 902,56% |
Beskikbare kontantvloei | -17,57 m | 68,87% |
Meer oor
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
HUB
Gestig
2000
Webwerf
Werknemers
10 452
